All stock lists
Healthcare Services Group Inc (HCSG)
NASDAQ: HCSG · Real-Time Price · USD
Healthcare · Medical Care Facilities
25.02-0.28 (-1.13%)
Insider Score
––Not scored
HCSG Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
HCSG analyst forecast
HCSG analyst consensus
Hold1 ratings
Buy 0 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
HCSG 12-month price target
No published price targets in the last 12 months.
Best analysts covering HCSG
- UBS100%success rate · 1 call
- Benchmark64%success rate · 11 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
HCSG analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Baird | Neutral | — | — | Reiterated | 2026-10-08 |
| — | UBS | Buy | — | — | Reiterated | 2026-07-08 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2026-04-23 |
| — | UBS | Buy | — | — | Reiterated | 2026-04-23 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-04-23 |
| — | Benchmark | Buy | — | — | Reiterated | 2026-04-23 |
| — | UBS | Buy | — | — | Reiterated | 2025-10-28 |
| — | Benchmark | Buy | — | — | Reiterated | 2025-10-23 |
| — | Macquarie | Outperform | — | — | Upgraded | 2025-07-29 |
| — | Baird | Neutral | — | — | Reiterated | 2025-07-24 |
| — | Benchmark | Buy | — | — | Reiterated | 2025-07-24 |
| — | Macquarie | Neutral | — | — | Reiterated | 2025-04-28 |
| — | UBS | Buy | — | — | Upgraded | 2025-04-24 |
| — | Baird | Neutral | — | — | Reiterated | 2025-04-24 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-12-19 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-10-24 |
| — | Baird | Neutral | — | — | Reiterated | 2024-10-24 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-07-25 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-07-25 |
| — | Baird | Neutral | — | — | Reiterated | 2024-07-25 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-02-15 |
| — | UBS | Neutral | — | — | Reiterated | 2024-02-15 |
| — | Benchmark | Buy | — | — | Reiterated | 2024-02-15 |
| — | Baird | Neutral | — | — | Reiterated | 2024-02-15 |
| — | Benchmark | Buy | — | — | Reiterated | 2023-12-22 |
| — | Benchmark | Buy | — | — | Reiterated | 2023-10-26 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2023-10-26 |
| — | Benchmark | Buy | — | — | Reiterated | 2023-08-31 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2023-08-01 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2023-07-27 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2023-04-28 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2023-04-27 |
| — | Jefferies | Hold | — | — | Upgraded | 2023-03-24 |
| — | Benchmark | Buy | — | — | Reiterated | 2023-02-21 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2023-02-17 |
| — | RBC Capital | Outperform | — | — | Upgraded | 2023-02-17 |
| — | Benchmark | Buy | — | — | Upgraded | 2022-10-20 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2022-10-20 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2022-10-20 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2022-04-21 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2022-04-21 |
| — | Jefferies | Underperform | — | — | Downgraded | 2022-02-10 |
| — | RBC Capital | Perform | — | — | Reiterated | 2022-01-03 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2021-10-22 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2021-10-21 |
| — | William Blair | Market Perform | — | — | Downgraded | 2021-10-20 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2021-07-22 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2021-07-21 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2021-02-11 |
| — | Credit Suisse | Neutral | — | — | Reiterated | 2020-10-22 |
| — | Baird | Neutral | — | — | Downgraded | 2020-07-23 |
| — | Northland Capital Markets | Market Perform | — | — | Downgraded | 2020-07-07 |
| — | Benchmark | Hold | — | — | Downgraded | 2020-07-06 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2020-04-22 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2020-04-22 |
| — | Baird | Outperform | — | — | Upgraded | 2020-04-20 |
| — | RBC Capital | Perform | — | — | Reiterated | 2019-11-22 |
| — | Benchmark | Buy | — | — | Reiterated | 2019-10-23 |
| — | Stifel Nicolaus | Sell | — | — | Reiterated | 2019-07-24 |
| — | Sidoti & Co. | Buy | — | — | Reiterated | 2019-07-24 |
HCSG earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-04-22 | 0.22 | 0.37 | $460.0M | $462.8M |
| 2026-07-22 | 0.22 | 0.32 | $471.2M | $470.8M |
| 2026-10-21 | 0.24 | 0.36 | $480.8M | $479.6M |
| 2027-02-10 | 0.27 | 0.00 | $530.4M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.